Ann: CEO's presentation to AGM and market update, page-2

Looking back the 6 months plus since we head anything other than mandatory reporting from LCT the two main active programs should by rights be well in progress . Both ( Migraine and Obesity) say completion to license from Nov 19 to March 21. So already 6 months in. Maybe we will hear soon if they are progressing to plan / virus impact etc - have the 48 patients across both studies been selected for example. I assume the patent Auckland Uni ( professor Brimble) was working on during the lock down was/is Migraine related? An update from Ken Taylor on all his phone calls trying to get NT Cell off and running again would also be good. Something / anything to give us reassurance they are still a going concern would be a bonus.